References
Morice MC, Serruys PW, Sousa JE, et al. A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. N Engl J Med 2002; 346:1773–1780.
Moses JW, Leon MB, Popma JJ, et al. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med 2003; 349:1315–1323.
Lomos PA, Hoye A, Goedhart D, et al. Clinical, angiographic, and procedural predictors angiographic restenosis after sirolimus-eluting etent implantation in complex patients: an evaluation from the rapamycineluting stent evaluated at rotterdam cardiology hospital (RESEARCH) study. Circulation 2004;109: 1366–1370.
Marx N, Wohrle J, Nusser T, et al. Pioglitazone reduces neointima volume after coronary stent implantation: a randomized, placebo-controlled, double-blind trial in nondiabetic patients. Circulation 2005;112: 2792–2798.
Chen KJ, Shi DZ, Xu H, et al. XS0601 reduces the incidence of restenosis: a perspective study of 335 patients undergoing PCI in China. CMJ 2006; 119: 6–13.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Zhang, Mz. The prevention and treatment of restenosis in the era of drug-eluting stent. Chin. J Integ. Med. 13, 6–7 (2007). https://doi.org/10.1007/s11655-007-0006-z
Received:
Issue Date:
DOI: https://doi.org/10.1007/s11655-007-0006-z